TITLE:
Study of the Safety and Efficacy of SU-011,248 in Adult Patients With Advanced Kidney Cancer

CONDITION:
Kidney Neoplasms

INTERVENTION:
SU-011,248

SUMMARY:

      The primary goal of the study is to evaluate the effectiveness and safety of SU-011,248 as a
      treatment for metastatic kidney cancer.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Eligible patients must be at least 18 years of age with a diagnosis of metastatic
             kidney cancer.

          -  The patient's kidney cancer must have gotten worse during/after previous
             cytokine-based therapy was given.

          -  Any side effects from prior therapy must have subsided, and blood and urine tests
             must show adequate bone marrow, liver, and kidney function

        Exclusion Criteria:

          -  Prior treatment with any systemic therapy other than 1 prior cytokine-based treatment
             regimen;

          -  Prior surgical resection of or irradiation to the only site of measurable disease;

          -  Ongoing severe hematuria;

          -  Other active second malignancy;

          -  Cardiovascular diseases or conditions within the last 12 months;

          -  Known brain metastases;

          -  Known HIV-positive or AIDS-related illness;

          -  Pregnant or breast-feeding women;

          -  Current participation in other clinical trials;

          -  Other severe acute or chronic medical conditions.
      
